<DOC>
	<DOCNO>NCT00838630</DOCNO>
	<brief_summary>The objective randomized , single-dose , two-way evaluation compare bioequivalence test cilostazol formulation equivalent oral dose commercially available cilostazol test population 36 adult subject fasting condition .</brief_summary>
	<brief_title>Cilostazol 100 mg Tablet Formulations Under Fasting Conditions</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Methods : FDA bioequivalence statistical method</detailed_description>
	<mesh_term>Cilostazol</mesh_term>
	<criteria>Sex : Male Female ; similar proportion prefer . Female subject must surgically sterile least six ( 6 ) month postmenopausal least one ( 1 ) year . Age : At least 18 year . Weight : Body Mass Index ( BMI ) 30 less . Qualifying subject must good health physical condition determine medical history , complete physical examination , laboratory test , obtain within four ( 4 ) week prior study start . The subject may history significant past illness expect affect investigation . The normal status subject confirm follow procedure : Laboratory Tests : Hemoglobin , hematocrit , RBC , WBC , differential count , serum electrolyte ( Na , K , Cl ) , fast blood glucose , BUN , bilirubin , creatinine , AST , ALT , LD , alkaline phosphatase , urinalysis . HIV , Hepatitis B , Hepatitis C , drug abuse test do screening purpose . Urine drug abuse test repeat checkin . Female subject serum pregnancy test do screen urine pregnancy test prior study period checkin . Laboratory value great 20 % normal range qualify unless specifically accept ( comment ) Principal Investigator . Results HIV , Hepatitis B , Hepatitis C , drug abuse must negative nonreactive subject qualify study . Electrocardiogram A 12lead electrocardiogram ( ECG ) obtain subject . The original tracing , plus interpretation , include case report form packet . Subjects must read sign Consent Form . History treatment alcoholism , substance abuse , drug abuse within past 24 month . History sensitivity cilostazol , quinolones , antiplatelet drug . History malignancy , stroke , diabetes , cardiac , renal liver disease serious illness . History GERD ( gastroesophageal reflux disease ) , malabsorption syndrome , colon cancer , chronic colitis , include Crohn 's disease . History treatment pulmonary obstruction asthma within past five ( 5 ) year . History severe headache migraine . History glaucoma . History chronic infectious disease . History psychiatric disorder . History thyroid disorder/disease . History hypertension . Females capable become pregnant lactating . Inability read and/or sign consent form . Treatment investigational drug four ( 4 ) week prior initial dose study . Subjects donate blood within four ( 4 ) week prior initial dose study . Subjects smoke use tobacco product currently use nicotine product ( patch , gum , etc. ) . Three month abstinence require .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>